AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2016

Mar 9, 2016

34301_dirs_2016-03-09_1fc46431-a57b-429f-905b-a26c143d3183.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2016-03-09

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-09	Common Stock	P	50000	$0.1886	Acquired	270059	Indirect
2016-03-09	Common Stock	P	100000	$.1886	Acquired	753385	Indirect

Footnotes

F1: These securities are owned by the Dave Rickey and Daughters Foundation Charitable Trust.

F2: These securities are owned by David M Rickey Trustee
The David M Rickey Trust u/a DTD 5/8/2002

F3: The shares were purchased in multiple open market transactions ranging in price from $0.1834 to $0.1900 per share, with a weighted average price of $0.1886 (as reported above).